Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

89Zr-pembrolizumab-PET Imaging in Patients With Locally Advanced or Metastatic Melanoma or Non-small Cell Lung Cancer

NCT02760225 is registered in ClinicalTrials.gov with University Medical Center Groningen as lead sponsor.

NCT NCT02760225
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02760225 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
89Zr-pembrolizumab-PET Imaging in Patients With Locally Advanced or Metastatic Melanoma or Non-small Cell Lung Cancer
Lead sponsor
University Medical Center Groningen
Phase
Not applicable
Overall status
Completed
Start date
October 24, 2016
Completion date
September 30, 2020
Enrollment
18 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

melanoma, non-small cell lung cancer